Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Eshleman

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Chemistry|February 1, 1990
Massive theophylline overdose with atypical metabolic abnormalitiesS H Eshleman, L M Shaw
Transfusion|June 24, 2000
Automated RBC exchange transfusion:treatment for cerebral malariaE G Weir, K E King, P M Ness, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|February 15, 2000
Improved detection of human immunodeficiency virus type 1 variants by analysis of replicate amplification reactions: relevance to studies of human immunodeficiency virus type 1 vertical transmissionG Becker-Pergola, J L Mellquist, J R Eshleman, et al.
AIDS Research and Human Retroviruses|May 29, 2000
Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adultsG Becker-Pergola, P Kataaha, L Johnston-Dow, et al.
Journal of Clinical Microbiology|November 29, 2001
Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from UgandaM Mracna, G Becker-Pergola, J Dileanis, et al.
AIDS Research and Human Retroviruses|August 24, 2000
Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan womenG Becker-Pergola, J L Mellquist, L Guay, et al.
AIDS Research and Human Retroviruses|July 10, 2004
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012S H Eshleman, L A Guay, A Mwatha, et al.
Journal of Clinical Microbiology|April 3, 2001
Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samplesS Cunningham, B Ank, D Lewis, et al.
The Journal of Infectious Diseases|August 18, 2001
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study)S H Eshleman, G Becker-Pergola, M Deseyve, et al.
AIDS (London, England)|September 13, 2000
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmissionJ B Jackson, G Becker-Pergola, L A Guay, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Chemistry|February 1, 1990
Massive theophylline overdose with atypical metabolic abnormalitiesS H Eshleman, L M Shaw
Transfusion|June 24, 2000
Automated RBC exchange transfusion:treatment for cerebral malariaE G Weir, K E King, P M Ness, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|February 15, 2000
Improved detection of human immunodeficiency virus type 1 variants by analysis of replicate amplification reactions: relevance to studies of human immunodeficiency virus type 1 vertical transmissionG Becker-Pergola, J L Mellquist, J R Eshleman, et al.
AIDS Research and Human Retroviruses|May 29, 2000
Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adultsG Becker-Pergola, P Kataaha, L Johnston-Dow, et al.
Journal of Clinical Microbiology|November 29, 2001
Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from UgandaM Mracna, G Becker-Pergola, J Dileanis, et al.
AIDS Research and Human Retroviruses|August 24, 2000
Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan womenG Becker-Pergola, J L Mellquist, L Guay, et al.
AIDS Research and Human Retroviruses|July 10, 2004
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012S H Eshleman, L A Guay, A Mwatha, et al.
Journal of Clinical Microbiology|April 3, 2001
Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samplesS Cunningham, B Ank, D Lewis, et al.
The Journal of Infectious Diseases|August 18, 2001
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study)S H Eshleman, G Becker-Pergola, M Deseyve, et al.
AIDS (London, England)|September 13, 2000
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmissionJ B Jackson, G Becker-Pergola, L A Guay, et al.
Pageof 2